ZOOMD TECHNOLOGIES LTD (ZOMD.CA)

CA98981L1004 - Common Stock

0.44  -0.04 (-8.33%)

Fundamental Rating

4

Taking everything into account, ZOMD scores 4 out of 10 in our fundamental rating. ZOMD was compared to 70 industry peers in the Software industry. ZOMD has an average financial health and profitability rating. ZOMD is valued correctly, but it does not seem to be growing.



5

1. Profitability

1.1 Basic Checks

ZOMD had positive earnings in the past year.
In the past year ZOMD had a positive cash flow from operations.
ZOMD had negative earnings in 4 of the past 5 years.
In multiple years ZOMD reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 10.91%, ZOMD belongs to the top of the industry, outperforming 89.86% of the companies in the same industry.
Looking at the Return On Equity, with a value of 20.96%, ZOMD belongs to the top of the industry, outperforming 86.96% of the companies in the same industry.
ZOMD has a better Return On Invested Capital (14.14%) than 89.86% of its industry peers.
Industry RankSector Rank
ROA 10.91%
ROE 20.96%
ROIC 14.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ZOMD has a Profit Margin of 6.42%. This is in the better half of the industry: ZOMD outperforms 79.71% of its industry peers.
ZOMD's Operating Margin of 7.91% is fine compared to the rest of the industry. ZOMD outperforms 76.81% of its industry peers.
With a Gross Margin value of 37.91%, ZOMD perfoms like the industry average, outperforming 43.48% of the companies in the same industry.
In the last couple of years the Gross Margin of ZOMD has grown nicely.
Industry RankSector Rank
OM 7.91%
PM (TTM) 6.42%
GM 37.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.32%
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZOMD is creating some value.
There is no outstanding debt for ZOMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 2.38 indicates that ZOMD is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.38, ZOMD is doing good in the industry, outperforming 62.32% of the companies in the same industry.
The Debt to FCF ratio of ZOMD is 1.06, which is an excellent value as it means it would take ZOMD, only 1.06 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.06, ZOMD is in the better half of the industry, outperforming 79.71% of the companies in the same industry.
ZOMD has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
ZOMD has a Debt to Equity ratio of 0.28. This is comparable to the rest of the industry: ZOMD outperforms 53.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.06
Altman-Z 2.38
ROIC/WACC1.51
WACC9.37%

2.3 Liquidity

A Current Ratio of 1.42 indicates that ZOMD should not have too much problems paying its short term obligations.
ZOMD has a Current ratio (1.42) which is comparable to the rest of the industry.
ZOMD has a Quick Ratio of 1.42. This is a normal value and indicates that ZOMD is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.42, ZOMD perfoms like the industry average, outperforming 55.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 130.14% over the past year.
The Revenue has decreased by -1.73% in the past year.
The Revenue has been growing by 8.10% on average over the past years. This is quite good.
EPS 1Y (TTM)130.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%377.76%
Revenue 1Y (TTM)-1.73%
Revenue growth 3Y8.1%
Revenue growth 5YN/A
Sales Q2Q%58.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.67, which indicates a correct valuation of ZOMD.
89.86% of the companies in the same industry are more expensive than ZOMD, based on the Price/Earnings ratio.
ZOMD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 30.45.
Industry RankSector Rank
PE 14.67
Fwd PE N/A

4.2 Price Multiples

ZOMD's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ZOMD is cheaper than 91.30% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ZOMD is valued cheaply inside the industry as 89.86% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.29
EV/EBITDA 5.47

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ZOMD!.
Industry RankSector Rank
Dividend Yield N/A

ZOOMD TECHNOLOGIES LTD

TSX-V:ZOMD (9/17/2024, 7:00:00 PM)

0.44

-0.04 (-8.33%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap43.37M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 14.67
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.91%
ROE 20.96%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.91%
PM (TTM) 6.42%
GM 37.91%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)130.14%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.73%
Revenue growth 3Y8.1%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y